Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
502 studies found for:    "Anemia, Hemolytic, Congenital"
Show Display Options
Rank Status Study
1 Recruiting Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Conditions: Congenital Hemolytic Anemia;   Diamond-Blackfan Anemia
Interventions: Procedure: Radiotherapy;   Drug: Alemtuzumab (Campath  );   Drug: Sirolimus (Rapamune  )
2 Recruiting Pyruvate Kinase Deficiency Natural History Study
Conditions: Pyruvate Kinase Deficiency;   Congenital Non-Spherocytic Hemolytic Anemia
3 Terminated The Dallas Hereditary Spherocytosis Cohort Study
Condition: Hereditary Spherocytosis
4 Recruiting SCD-Haplo: A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
Condition: Sickle Cell Disease
Interventions: Procedure: Haploidentical Transplant;   Drug: Alemtuzumab;   Radiation: Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Sirolimus
5 Unknown  Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
Condition: Beta-Thalassemia
Intervention: Drug: Mozobil
6 Completed Sickle Cell Disease: A Retrospective Chart Review
Condition: Sickle Cell Anemia
7 Recruiting Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
Condition: Sickle Cell Disease
8 Not yet recruiting Role of Vitamin C to Augment Iron Chelation With DFP or DFX
Conditions: Vitamin c;   Thalassemia Major;   Iron Chelation
Interventions: Drug: Vitamin C, Defriprone, deferisarox;   Drug: deferiprone , deferesarox
9 Completed
Has Results
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
Condition: Anemia, Sickle Cell
Interventions: Drug: Nitric Oxide;   Drug: Placebo
10 Completed Study of Vitamin D in Children With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Vitamin D3
11 Recruiting Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Conditions: Sickle Cell Anemia;   Sickle Cell β+ or β0 Thalassemia
12 Terminated A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention: Drug: Bosentan
13 Active, not recruiting The Feasibility of Text Messaging to Assess Secondhand Smoke Exposure Among Youngsters With Cancer or Sickle Cell Disease
Conditions: Cancer;   Sickle Cell Disease
Interventions: Other: Text messaging;   Other: Questionnaire;   Other: Interviews
14 Terminated Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)
Condition: Sickle Cell Anemia
Intervention: Drug: Hydroxyurea
15 Completed Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Conditions: Beta-thalassemia;   Myelodysplastic Syndromes;   Fanconi Syndrome;   Anemia, Diamond-Blackfan;   Anemia, Aplastic
Intervention: Drug: Deferasirox
16 Completed Pain in Sickle Cell Epidemiologic Study
Conditions: Blood Disease;   Anemia, Sickle Cell
17 Active, not recruiting The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2
Condition: Sickle Cell Disease
Intervention: Other: Brigance Preschool Screen -II
18 Recruiting Sickle Cell Clinical Research and Intervention Program
Condition: Sickle Cell Disease
19 Completed MAST - Magnesium for Sickle Cell Acute Crisis in Children
Condition: Anemia, Sickle Cell
Interventions: Drug: Magnesium Sulfate;   Drug: Normal Saline
20 Unknown  Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia
Conditions: Thalassemia Major;   Thalassemia Intermedia;   Pulmonary Arterial Hypertension
Intervention: Other: Physician standard-of-care according to ESC/ERS Guidelines

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years